BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Caris Life Sciences 

6655 North MacArthur Boulevard

Irving  Texas  75039  U.S.A.
Phone: 214-277-8700 or 800-979-8292 Fax: 214-596-7425


SEARCH JOBS










 Company News
Caris Life Sciences Establishes The Caris Centers Of Excellence For Precision Medicine Network™ To Develop Guidelines And Standards Of Care For Use Of Molecular Profiling In Oncology 1/20/2015 7:58:04 AM
Caris Life Sciences Molecular Intelligence™ Identifies Therapeutic Options, Including Novel Immunotherapeutics, For Patients With Rare, Advanced Anal Squamous Cell Carcinoma 1/16/2015 9:41:45 AM
Caris Life Sciences' Multiplatform Tumor Profiling Of Hepatocellular And Biliary Tract Carcinomas Yields Insights Into Novel And Conventional Therapeutic Options 1/15/2015 10:43:03 AM
Multiplatform Tumor Profiling From Caris Life Sciences Molecular Intelligence™ Identifies Therapeutic Options For Patients With TKI-Resistant Gastrointestinal Stromal Tumors 1/15/2015 10:37:30 AM
Caris Life Sciences Presents Two Studies Demonstrating Utility Of Tumor Profiling: Likelihood Of Response To Immunotherapeutics In HER2-Positive Breast Cancer And The Largest Case Series Comparing Male Breast Cancer To Female Breast Cancer Patients 12/11/2014 7:22:13 AM
Caris Life Sciences Study Shows Molecular Profiling May Expand Use Of PD-1 And PD-L1 Inhibitors To Wide Variety Of Cancers 11/12/2014 7:15:34 AM
Caris Life Sciences Release: Large Studies Show Caris Molecular Intelligence™ Identifies Targets With Therapeutic Implications To Help Physicians Select Regimens To Manage Patients With Lung Tumors 10/30/2014 8:30:58 AM
Caris Life Sciences Release: Caris Molecular Intelligence™ Identifies Large Number Of Actionable Biomarkers In Urothelial Carcinoma (UC) 10/2/2014 9:01:33 AM
Caris Life Sciences Selects IBM Corporation (IBM) To Accelerate Use Of Molecular Profiling In Cancer Treatment Selection 9/17/2014 8:27:03 AM
Feist-Weiller Cancer Center Partners With Caris Life Sciences To Establish A Clinical Molecular Profiling Program 8/12/2014 8:30:46 AM
1234567